Maximizing Recruitment in Oncology Trials
Over the last several decades, patient recruitment for clinical trials has remained a major barrier to rapid execution of drug development programs. Sponsors are spending 20% to 60% of their time recruiting patients and about 40% of their study budgets on this task. This problem is particularly acute in oncology and with a new focus on immuno-oncology recruitment has become even more challenging.
This playbook highlights unique expertise, tools and other attributes that can help companies excel in oncology clinical trials.